Hjem › Prostatakræft › Minnesota

Prostatakræft kliniske forsøg i Minnesota

48 studier for Prostatakræft søger deltagere på steder i Minnesota.

Byer i Minnesota

Officiel studietekst (engelsk)

Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial

Sanford Joe Lueken Cancer Center, Bemidji
Coborn Cancer Center at Saint Cloud Hospital, Saint Cloud

RekruttererFase 3

Alder 18 og opefter · Mænd · Opdateret 2. okt. 2026 · NCT06931340

Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial

Coborn Cancer Center at Saint Cloud Hospital, Saint Cloud

RekruttererFase 3

Alder 18 og opefter · Mænd · Opdateret 2. okt. 2026 · NCT07200830

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Riverwood Healthcare Center, Aitkin
Mayo Clinic Health System in Albert Lea, Albert Lea
Essentia Health - Baxter Clinic, Baxter
og 48 flere

RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne

Alder 40 til 75 · Alle køn · Opdateret 2. okt. 2026 · NCT05334069

Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial

Essentia Health Saint Joseph's Medical Center, Brainerd
Essentia Health Cancer Center, Duluth
Coborn Cancer Center at Saint Cloud Hospital, Saint Cloud

RekruttererFase 2

Alder 18 og opefter · Alle køn · Opdateret 2. okt. 2026 · NCT06632977

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

Health Partners Frauenshuh Cancer Center, Saint Louis Park
Health Partners Cancer Center at Regions Hospital, Saint Paul

RekruttererFase 2

Alder 18 og opefter · Alle køn · Opdateret 1. okt. 2026 · NCT06172478

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Essentia Health - Deer River Clinic, Deer River
Essentia Health Cancer Center, Duluth
Fairview Southdale Hospital, Edina
og 8 flere

RekruttererFase 2

Alder 18 og opefter · Alle køn · Opdateret 30. sep. 2026 · NCT03866382

A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer

University Of Minnesota, Minneapolis

RekruttererFase 1

Alder 18 og opefter · Mænd · Opdateret 28. sep. 2026 · NCT06095089

Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer

M Health Fairview Clinics and Surgery Center, Minneapolis

RekruttererFase 1

Alder 18 og opefter · Mænd · Opdateret 25. sep. 2026 · NCT06801236

A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

Avera Cancer Institute - Marshall ( Site 0122), Marshall
HealthPartners Cancer Research Center-HealthPartners Frauenshuh Cancer Center ( Site 0072), Saint Louis Park
HealthPartners Cancer Research Center-HealthPartners Cancer Center at Regions Hospital ( Site 0092), Saint Paul

RekruttererFase 3

Alder 18 og opefter · Alle køn · Opdateret 25. sep. 2026 · NCT06136650

A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer

Minnesota Oncology Hematology PA, Minneapolis
University of Minnesota Medical Center Fairview, Minneapolis

RekruttererFase 3

Alder 18 og opefter · Mænd · Opdateret 22. sep. 2026 · NCT07213674

A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation

Research Site, Rochester

RekruttererFase 3

Alder 18 og opefter · Mænd · Opdateret 18. sep. 2026 · NCT06952803

Study of PSMA-targeted Therapy and Androgen Receptor Suppression in Low-volume Metastatic ProstatE Cancer: SPARKLE Trial

Mayo Clinic in Rochester, Rochester

RekruttererFase 2

Alder 18 og opefter · Mænd · Opdateret 18. sep. 2026 · NCT07650240

A Study of GSK5458514 Administered Alone or In Combination With Other Anti-Cancer Agents in Participants With Prostate Cancer

GSK Investigational Site, Rochester

RekruttererFase 1/2

Alder 18 og opefter · Mænd · Opdateret 18. sep. 2026 · NCT06990880

Carboplatin or Olaparib for BRcA Deficient Prostate Cancer

Minneapolis VA Health Care System, Minneapolis, MN, Minneapolis

RekruttererFase 2

Alder 18 og opefter · Mænd · Opdateret 17. sep. 2026 · NCT04038502

A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)

Mayo Clinic in Rochester, Minnesota-Mayo Clinic Comprehensive Cancer Center ( Site 0078), Rochester
HealthPartners Cancer Research Center-HealthPartners Frauenshuh Cancer Center ( Site 0032), Saint Louis Park
HealthPartners Cancer Center at Regions Hospital ( Site 0052), Saint Paul

RekruttererFase 3

Alder 18 og opefter · Mænd · Opdateret 17. sep. 2026 · NCT06925737

Sacral Neuromodulation for Male Overactive Bladder (MOAB)

Mayo Clinic, Rochester

Rekrutterer

Alder 18 og opefter · Mænd · Opdateret 14. sep. 2026 · NCT06511141

Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy

Mayo Clinic- Rochester, Rochester

RekruttererFase 3

Alder 18 og opefter · Mænd · Opdateret 11. sep. 2026 · NCT06056830

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

Sanford Joe Lueken Cancer Center, Bemidji
Essentia Health Saint Joseph's Medical Center, Brainerd
Minnesota Oncology Hematology PA-Chaska, Chaska
og 16 flere

RekruttererFase 3

Alder 18 og opefter · Mænd · Opdateret 10. sep. 2026 · NCT05946213

The Vanguard Study: Testing a New Way to Screen for Cancer

Minneapolis VA Medical Center, Minneapolis

RekruttererFrivillige med god helbredstilstand velkomne

Alder 45 til 75 · Alle køn · Opdateret 2. sep. 2026 · NCT06995898

Phase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate Cancer

Research Site, Minneapolis

RekruttererFase 1/2

Alder 18 til 99 · Mænd · Opdateret 27. aug. 2026 · NCT07590934

A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate or Darolutamide

Masonic Cancer Center, Minneapolis

RekruttererFase 2

Alder 18 og opefter · Mænd · Opdateret 21. aug. 2026 · NCT06844383

Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

Minnesota Oncology - Burnsville, Burnsville
Minnesota Oncology Hematology PA-Chaska, Chaska
Mercy Hospital, Coon Rapids
og 21 flere

RekruttererFase 3

Alder 18 og opefter · Mænd · Opdateret 19. aug. 2026 · NCT04423211

Water Vapor Ablation for Prostate Cancer: Long-Term Registry

Minnesota Urology, Woodbury

RekruttererObservationsstudie

Alle aldre · Mænd · Opdateret 18. aug. 2026 · NCT07455058

FOG-001 in Locally Advanced or Metastatic Solid Tumors

M Health Fairview University of Minnesota Medical Center, Minneapolis
Mayo Clinic, Rochester

RekruttererFase 1/2

Alder 18 og opefter · Alle køn · Opdateret 17. aug. 2026 · NCT05919264

Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)

University of Minnesota Medical Center, Minneapolis
Mayo Clinic, Rochester

RekruttererFase 1

Alder 18 til 100 · Mænd · Opdateret 13. aug. 2026 · NCT05519449

Adaptive Radiation Therapy (ART) Stereotactic Ablative Body Radiotherapy (SABR) for Primary Localized Prostate Cancer

Mayo Clinic Health System in Albert Lea, Albert Lea
Mayo Clinic Health System-Mankato, Mankato
Mayo Clinic in Rochester, Rochester

Rekrutterer

Alder 18 og opefter · Mænd · Opdateret 30. jul. 2026 · NCT06325046

MRI-guided Transurethral Urethral Ultrasound Ablation for the Treatment of Low to Intermediate Grade Prostate Cancer

Mayo Clinic in Rochester, Rochester

Rekrutterer

Alder 45 til 80 · Mænd · Opdateret 22. jul. 2026 · NCT05438563

Stereotactic Body Radiation Therapy Plus Immediate or Delayed Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy or Salvage Radiation Therapy for the Treatment of Prostate Cancer, DIVINE Trial

Mayo Clinic in Rochester, Rochester

RekruttererFase 2

Alder 18 og opefter · Mænd · Opdateret 20. jul. 2026 · NCT06378866

Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

Riverwood Healthcare Center, Aitkin
Essentia Health - Baxter Clinic, Baxter
Essentia Health Saint Joseph's Medical Center, Brainerd
og 18 flere

RekruttererFase 3

Alder 18 og opefter · Mænd · Opdateret 14. jul. 2026 · NCT06592924

A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)

Mayo Clinic, Rochester

RekruttererFase 1

Alder 18 og opefter · Mænd · Opdateret 9. jul. 2026 · NCT07103018

Study of ORIC-944 in Patients With Metastatic Prostate Cancer

Minnesota Oncology Hematology, Minneapolis

RekruttererFase 1

Alder 18 og opefter · Mænd · Opdateret 9. jul. 2026 · NCT05413421

Study Evaluating the Safety, Tolerability, and Efficacy of Xaluritamig in Combination With Androgen Receptor Pathway Inhibitors in Participants With Metastatic Hormone-sensitive Prostate Cancer

University of Minnesota, Minneapolis

RekruttererFase 1

Alder 18 og opefter · Mænd · Opdateret 2. jul. 2026 · NCT07140900

Integrated Cancer Repository for Cancer Research

Riverwood Healthcare Center, Aitkin
Essentia Health-St. Joseph's Medical Center, Brainerd
Essentia Health - Duluth Clinic, Duluth
og 2 flere

RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne

Alder 19 til 110 · Alle køn · Opdateret 29. jun. 2026 · NCT02012699

Breathing Practice for Brain and Mental Health in Cancer and Neurodegenerative Diseases

Mayo Clinic in Rochester, Rochester

RekruttererFrivillige med god helbredstilstand velkomne

Alder 18 til 85 · Alle køn · Opdateret 10. jun. 2026 · NCT06788886

Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer

Mayo Clinic Rochester, Rochester

RekruttererFase 4

Alder 18 til 100 · Mænd · Opdateret 4. jun. 2026 · NCT05803941

A Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate Cancer

Research Site, Rochester

RekruttererFase 1

Alder 18 og opefter · Mænd · Opdateret 12. maj 2026 · NCT06879041

Axelopran for Advanced Cancer in Patients Receiving Opioids

HealthPartners Frauenshuh Cancer Research Center, Saint Louis Park
HealthPartners Cancer Center at Regions Hospital, Saint Paul

RekruttererFase 2

Alder 18 og opefter · Alle køn · Opdateret 5. maj 2026 · NCT07354919

Improvements in Dynamic Contrast-Enhanced MR Angiography and Perfusion and Non-Contrast MRI

Mayo Clinic in Rochester, Rochester

RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne

Alder 18 og opefter · Alle køn · Opdateret 17. apr. 2026 · NCT06315595

A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies

Mayo Clinic, Rochester

RekruttererFase 1/2

Alder 18 og opefter · Alle køn · Opdateret 27. mar. 2026 · NCT06395519

Screening and Staging of Benign vs Malignant Pelvic Abnormalities

Mayo Clinic in Rochester, Rochester

RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne

Alder 18 og opefter · Alle køn · Opdateret 17. feb. 2026 · NCT07407959

Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.